Invention Grant
- Patent Title: Humanized or chimeric CD3 antibodies
-
Application No.: US14902757Application Date: 2014-07-04
-
Publication No.: US10465006B2Publication Date: 2019-11-05
- Inventor: Edward Van Den Brink , Joost J. Neijssen , Aran Frank Labrijn , Joyce Meesters , Janine Schuurman , Paul Parren
- Applicant: GENMAB
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: WOPCT/EP13/64330 20130705; DK201400009 20140109; WOPCT/EP14/50340 20140109
- International Application: PCT/EP2014/064326 WO 20140704
- International Announcement: WO2015/001085 WO 20150108
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/10 ; C07K16/32 ; C07K16/42 ; G01N33/68 ; A61K39/00
Abstract:
The present invention relates to humanized or chimeric antibodies binding CD3. It furthermore relates to bispecific antibodies, compositions, pharmaceutical compositions, use of said antibodies in the treatment of a disease, and method of treatment.
Public/Granted literature
- US20160168247A1 HUMANIZED OR CHIMERIC CD3 ANTIBODIES Public/Granted day:2016-06-16
Information query
